Capstone Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.24M Buy
49,800
+22,900
+85% +$2.04M 0.01% 456
2025
Q4
$2.13M Sell
26,900
-21,500
-44% -$1.69M ﹤0.01% 601
2025
Q3
$3.87M Buy
48,400
+19,000
+65% +$1.62M 0.01% 548
2025
Q2
$2.67M Sell
29,400
-59,800
-67% -$5.46M 0.01% 552
2025
Q1
$8.36M Sell
89,200
-30,600
-26% -$2.74M 0.02% 344
2024
Q4
$10.9M Buy
119,800
+39,300
+49% +$3.75M 0.03% 340
2024
Q3
$8.36M Sell
80,500
-6,700
-8% -$683K 0.03% 340
2024
Q2
$8.46M Buy
87,200
+18,700
+27% +$1.73M 0.03% 339
2024
Q1
$6.17M Sell
68,500
-35,400
-34% -$3M 0.02% 378
2023
Q4
$8.28M Buy
103,900
+43,800
+73% +$3.29M 0.02% 385
2023
Q3
$4.27M Buy
60,100
+8,900
+17% +$665K 0.02% 474
2023
Q2
$3.94M Buy
51,200
+5,300
+12% +$410K 0.02% 444
2023
Q1
$3.45M Sell
45,900
-84,800
-65% -$6.31M 0.02% 449
2022
Q4
$10.3M Buy
130,700
+4,400
+3% +$330K 0.08% 224
2022
Q3
$8.87M Sell
126,300
-1,200
-0.9% -$94.1K 0.05% 256
2022
Q2
$10.2M Sell
127,500
-161,800
-56% -$12.7M 0.05% 255
2022
Q1
$21.9M Sell
289,300
-287,400
-50% -$22.8M 0.06% 239
2021
Q4
$49.2M Sell
576,700
-13,400
-2% -$1.05M 0.08% 204
2021
Q3
$44.6M Buy
590,100
+82,500
+16% +$6.55M 0.09% 199
2021
Q2
$41.3M Sell
507,600
-45,900
-8% -$3.75M 0.09% 188
2021
Q1
$43.6M Sell
553,500
-115,900
-17% -$9.08M 0.13% 158
2020
Q4
$57.2M Buy
669,400
+199,600
+42% +$16.5M 0.19% 95
2020
Q3
$36.2M Buy
469,800
+107,200
+30% +$8.17M 0.19% 99
2020
Q2
$26.6M Buy
362,600
+75,300
+26% +$5.35M 0.18% 102
2020
Q1
$19.1M Sell
287,300
-189,300
-40% -$13.4M 0.31% 54
2019
Q4
$32.8M Buy
476,600
+75,400
+19% +$5.14M 0.18% 123
2019
Q3
$29.5M Buy
401,200
+108,600
+37% +$7.88M 0.2% 105
2019
Q2
$21M Buy
292,600
+120,000
+70% +$8.52M 0.15% 147
2019
Q1
$11.8M Buy
172,600
+72,400
+72% +$4.68M 0.11% 185
2018
Q4
$5.96M Buy
100,200
+35,400
+55% +$2.21M 0.07% 214
2018
Q3
$4.34M Buy
64,800
+51,100
+373% +$3.4M 0.05% 277
2018
Q2
$888K Buy
+13,700
New +$896K 0.01% 395
2017
Q1
Sell
-3,700
Closed -$242K 908
2016
Q4
$242K Buy
+3,700
New +$254K 0.01% 778
2016
Q1
Sell
-30,000
Closed -$2M 659
2015
Q4
$2M Sell
30,000
-56,800
-65% -$3.78M 0.05% 166
2015
Q3
$5.51M Sell
86,800
-12,200
-12% -$797K 0.13% 129
2015
Q2
$6.47M Sell
99,000
-52,300
-35% -$3.55M 0.09% 162
2015
Q1
$10.5M Buy
151,300
+114,000
+306% +$7.88M 0.17% 108
2014
Q4
$2.58M Buy
+37,300
New +$2.52M 0.04% 213
2014
Q1
Sell
-70,000
Closed -$4.56M 405
2013
Q4
$4.56M Hold
70,000
0.05% 215
2013
Q3
$4.15M Buy
+70,000
New +$4.15M 0.04% 228

Other funds holding CL

Capstone Investment Advisors's CL Position: Q1 2026 in Review

Capstone Investment Advisors increased its Colgate-Palmolive (CL) stake by 318% in Q1 2026, buying an estimated $11.2M and bringing the position to 165,075 shares worth $14.1M. The position accounts for 0.02% of the portfolio, ranked #236.

Capstone Investment Advisors first reported a position in CL in Q2 2014 and has held it in 32 quarters since. The position peaked at $16.6M in Q4 2014. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Capstone Investment Advisors held 165,075 shares of Colgate-Palmolive worth $14.1M as of Q1 2026.
  • Capstone Investment Advisors bought 125,624 Colgate-Palmolive shares in Q1 2026, an estimated $11.2M.
  • Colgate-Palmolive made up 0.02% of Capstone Investment Advisors's portfolio in Q1 2026, its #236 holding.
  • Capstone Investment Advisors first reported a position in Colgate-Palmolive in Q2 2014 and has held it in 32 quarters since.
  • Capstone Investment Advisors's Colgate-Palmolive position peaked at $16.6M in Q4 2014.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.